Gene · 3587
Papers3,503
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,503
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| IRF9 and XAF1 as Diagnostic Markers of Primary Sjogren Syndrome. | Comput Math Methods Med | 2022 | 36132546 | PubTator, text mining | PubMed |
| Regulatory Role of B Cells and Its Subsets in Hepatitis E Virus Infection. | Biomed Res Int | 2022 | 36132083 | PubTator, text mining | PubMed |
| Specific transcriptional programs differentiate ICOS from CD28 costimulatory signaling in human Naïve CD4+ T cells. | Front Immunol | 2022 | 36131938 | PubTator, text mining | PubMed |
| An anti-inflammatory activation sequence governs macrophage transcriptional dynamics during tissue injury in zebrafish. | Nat Commun | 2022 | 36127326 | PubTator, text mining | PubMed |
| Review of potential medical treatments for middle ear cholesteatoma. | Cell Commun Signal | 2022 | 36123729 | PubTator, text mining | PubMed |
| GBP2 acts as a member of the interferon signalling pathway in lupus nephritis. | BMC Immunol | 2022 | 36115937 | PubTator, text mining | PubMed |
| Genetic and immunologic evaluation of children with inborn errors of immunity and severe or critical COVID-19. | J Allergy Clin Immunol | 2022 | 36113674 | PubTator, text mining | PubMed |
| An overview of JAK/STAT pathways and JAK inhibition in alopecia areata. | Front Immunol | 2022 | 36110853 | PubTator, text mining | PubMed |
| CRISPR/Cas9 based blockade of IL-10 signaling impairs lipid and tissue homeostasis to accelerate atherosclerosis. | Front Immunol | 2022 | 36110841 | PubTator, text mining | PubMed |
| Direct and indirect effects of IFN-α2b in malignancy treatment: not only an archer but also an arrow. | Biomark Res | 2022 | 36104718 | PubTator, text mining | PubMed |
| Emerging roles of neutrophils in immune homeostasis. | BMB Rep | 2022 | 36104260 | PubTator, text mining | PubMed |
| Evaluation of effective factors on IL-10 signaling in B cells in patients with selective IgA deficiency | Eur Cytokine Netw | 2022 | 36102856 | PubTator, text mining | PubMed |
| Immune Infiltration-Related ceRNA Network Revealing Potential Biomarkers for Prognosis of Head and Neck Squamous Cell Carcinoma. | Dis Markers | 2022 | 36097539 | PubTator, text mining | PubMed |
| Impaired IL-23-dependent induction of IFN-γ underlies mycobacterial disease in patients with inherited TYK2 deficiency. | J Exp Med | 2022 | 36094518 | PubTator, text mining | PubMed |
| Higher susceptibility of males to bleomycin-induced pulmonary inflammation is associated with sex-specific transcriptomic differences in myeloid cells. | Toxicol Appl Pharmacol | 2022 | 36087614 | PubTator, text mining | PubMed |
| [Clinical characteristics and identification of a novel IL10RA variant in association with very early-onset inflammatory bowel disease]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2022 | 36082572 | PubTator, text mining | PubMed |
| Interleukin 4 Controls the Pro-Tumoral Role of Macrophages in Mammary Cancer Pulmonary Metastasis in Mice. | Cancers (Basel) | 2022 | 36077870 | PubTator, text mining | PubMed |
| COVID-19 vs. Cancer Immunosurveillance: A Game of Thrones within an Inflamed Microenviroment. | Cancers (Basel) | 2022 | 36077865 | PubTator, text mining | PubMed |
| Expression of Eosinophilic Subtype Markers in Patients with Kawasaki Disease. | Int J Mol Sci | 2022 | 36077487 | PubTator, text mining | PubMed |
| Longitudinal assessment of systemic steroid therapy on hyperinflammatory endothelial biomarker profiles and serology responses of COVID-19 patients. | J Transl Med | 2022 | 36076201 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3587/papers?page=32